185 related articles for article (PubMed ID: 10861435)
1. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Li CI; Weiss NS; Stanford JL; Daling JR
Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
[TBL] [Abstract][Full Text] [Related]
2. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
[TBL] [Abstract][Full Text] [Related]
3. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
4. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
[TBL] [Abstract][Full Text] [Related]
6. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI; Anderson BO; Daling JR; Moe RE
JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
10. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
11. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
Li CI; Daling JR; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Strom BL; Simon MS; Press MF; McDonald JA; Ursin G; Burkman RT; Deapen D; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):946-54. PubMed ID: 16702375
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in relation to breast cancer.
Chen CL; Weiss NS; Newcomb P; Barlow W; White E
JAMA; 2002 Feb; 287(6):734-41. PubMed ID: 11851540
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.
Calle EE; Feigelson HS; Hildebrand JS; Teras LR; Thun MJ; Rodriguez C
Cancer; 2009 Mar; 115(5):936-45. PubMed ID: 19156895
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement and breast cancer: implications of the Iowa Women's Health Study.
Mayer ME
Cleve Clin J Med; 1999; 66(10):608-10, 613. PubMed ID: 10598365
[TBL] [Abstract][Full Text] [Related]
16. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.
Kjartansdottir OJ; Sigurdardottir LG; Olafsdottir EJ; Jonasson JG; Ursin G; Tryggvadottir L
Breast Cancer Res Treat; 2017 Jun; 163(2):363-373. PubMed ID: 28281022
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States).
Newcomer LM; Newcomb PA; Potter JD; Yasui Y; Trentham-Dietz A; Storer BE; Longnecker MP; Baron JA; Daling JR
Cancer Causes Control; 2003 Apr; 14(3):225-33. PubMed ID: 12814201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
